血液ガスおよび電解質分析装置の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年

血液ガスおよび電解質分析装置市場の成長と動向：

Grand View Research Inc.の新しい調査によると、世界の血液ガスおよび電解質分析装置市場規模は、CAGR 4.5%を記録し、2030年までに37億1,000万米ドルに達する見込みです。

ICUや重症治療室における患者数の増加、高スループットで統合されたシステムに対する需要の増加は、血液ガスおよび電解質分析装置市場を牽引しそうな主な要因です。また、世界の老人人口の増加も、対象疾患の罹患率を高め、重篤な治療を必要とする患者の裾野を広げることで、予測期間中の市場成長に大きく寄与すると予想されます。さらに、検査メニューの拡大やポータブル機器への需要の高まりにより、マルチパラメーターモニタリング機器の出現が予測期間中の使用率を押し上げると予想されます。血液ガス分析計が利用可能になったことで、呼吸器疾患の頻繁な診断とモニタリングが可能になり、予後と治療の指針となるため、重症患者のケア強化に役立っています。短時間で測定できる高度な技術を備えたハンドヘルド機器に対する需要の高まりにより、よりコンパクトで洗練されたハンドヘルドのポイントオブケア機器が開発されています。例えば、OPTI CCA-TS2血液ガスおよび電解質分析装置は、革新的な光学技術を使用し、最小限のメンテナンスで迅速な結果を提供します。

血液ガスおよび電解質分析装置市場レポート・ハイライト

• 2023年の収益シェアは消耗品が66.28%で市場を独占し、予測期間中最も速い成長率で成長すると予測されます。
• 2023年の売上高シェアは46.98%で、臨床検査が市場を独占。急速に進歩するヘルスケア技術において、血液ガス分析装置（BGA）は臨床検査室にとって不可欠なものとなっており、患者の呼吸・代謝状態をリアルタイムで把握することができます。
• 2023年の血液ガスおよび電解質分析装置市場は北米が42.22%を占めました。洗練されたヘルスケアインフラの存在と有利な償還プランが、この地域の市場成長を促進すると予想される主な要因です。
• インドと中国の新興市場における医療インフラの急速な改善と相まって、高いアンメットニーズが存在することが、予測期間を通じてアジア太平洋地域の有利な成長率を後押しすると予想されます。大量の診断検査を扱う分散型ポイントオブケア診断施設に対する需要の高まりも、この地域の市場成長を促進すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血液ガスおよび電解質分析装置の市場変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 血液ガスおよび電解質分析装置市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 血液ガスおよび電解質分析装置市場：製品別推定・動向分析

• 世界の血液ガスおよび電解質分析装置市場：製品別ダッシュボード
• 世界の血液ガスおよび電解質分析装置市場：製品別変動分析
• 世界の血液ガスおよび電解質分析装置市場：製品別、収益別
• 機器
• 消耗品

第5章 血液ガスおよび電解質分析装置市場：最終用途別推定・動向分析

• 世界の血液ガスおよび電解質分析装置市場：最終用途別ダッシュボード
• 世界の血液ガスおよび電解質分析装置市場：最終用途別変動分析
• 世界の血液ガスおよび電解質分析装置市場：最終用途別、収益別
• 臨床検査室
• ポイントオブケア
• 診断センター
• その他

第6章 血液ガスおよび電解質分析装置市場：製品および最終用途の地域別推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年-2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネル パートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2023 年
  • Abbott
  • Meizhou Cornley High-Tech Co., Ltd.
  • Radiometer Medical ApS
  • EDAN Instruments, Inc.
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd
  • Fortress Diagnostics
  • Werfen
  • LifeHealth
  • Medica Corporation
  • OPTI Medical Systems, Inc.,
  • Sensa Core
  • Siemens Healthineers AG

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 5 Global Blood Gas and Electrolyte Analyzer, by Region, 2018 - 2030 (USD Million)
• Table 6 North America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
• Table 7 North America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 8 North America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 9 U.S. Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 10 U.S. Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 11 Canada Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 12 Canada Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 13 Europe Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
• Table 14 Europe Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 15 Europe Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 16 Germany Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 17 Germany Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 18 UK Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 19 UK Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 20 France Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 21 France Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 22 Italy Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 23 Italy Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 24 Spain Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 25 Spain Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 26 Denmark Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 27 Denmark Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 28 Sweden Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 29 Sweden Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 30 Norway Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 31 Norway Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 32 Asia Pacific Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 35 China Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 36 China Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 37 Japan Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 38 Japan Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 39 India Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 40 India Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 41 South Korea Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 42 South Korea Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 43 Australia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 44 Australia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 45 Singapore Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 46 Singapore Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 47 Malaysia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 48 Malaysia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 49 Indonesia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 50 Indonesia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 51 Thailand Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 52 Thailand Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 53 Vietnam Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 54 Vietnam Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 55 Philippines Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 56 Philippines Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 57 Latin America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
• Table 58 Latin America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 59 Latin America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 60 Brazil Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 61 Brazil Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 62 Mexico Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 63 Mexico Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 64 Argentina Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 65 Argentina Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 66 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
• Table 67 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 68 Middle East & Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 69 South Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 70 South Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 71 Saudi Arabia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 72 Saudi Arabia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 73 UAE Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 74 UAE Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
• Table 75 Kuwait Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
• Table 76 Kuwait Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Blood Gas and Electrolyte Analyzer Market Segmentation
• Fig. 8 Market Snapshot, 2023
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
• Fig. 16 Global Blood Gas and Electrolyte Analyzer Market, for Instruments, 2018 - 2030 (USD Million)
• Fig. 17 Global Blood Gas and Electrolyte Analyzer Market, for Consumables, 2018 - 2030 (USD Million)
• Fig. 18 Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
• Fig. 19 Global Blood Gas and Electrolyte Analyzer Market, for Clinical Laboratory, 2018 - 2030 (USD Million)
• Fig. 20 Global Blood Gas and Electrolyte Analyzer Market, for Point-of-care, 2018 - 2030 (USD Million)
• Fig. 21 Global Blood Gas and Electrolyte Analyzer Market, for Diagnostic Centers, 2018 - 2030 (USD Million)
• Fig. 22 Global Blood Gas and Electrolyte Analyzer Market, for Others, 2018 - 2030 (USD Million)
• Fig. 23 Regional Marketplace: Key Takeaways
• Fig. 24 Regional Outlook, 2023 & 2030
• Fig. 25 Global Blood Gas and Electrolyte Analyzer Market: Region Movement Analysis
• Fig. 26 North America Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 27 U.S. Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 28 Canada Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 29 Europe Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 30 Germany Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 31 UK Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 32 France Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 33 Italy Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 34 Spain Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 35 Denmark Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 36 Sweden Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 37 Norway Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 38 Asia Pacific Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 39 Japan Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 40 China Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 41 India Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 42 Australia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 43 South Korea Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 44 Singapore Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 45 Malaysia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 46 Indonesia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 47 Thailand Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 48 Vietnam Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 49 Philippines Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 52 Mexico Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 53 Argentina Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 55 South Africa Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 57 UAE Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)

Blood Gas And Electrolyte Analyzer Market Growth & Trends:

The global blood gas and electrolyte analyzer market size is expected to reach USD 3.71 billion by 2030, registering a CAGR of 4.5%, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Blood Gas And Electrolyte Analyzer Market Report Highlights:

• Consumables dominated the market with a revenue share of 66.28% in 2023 and is anticipated to grow at the fastest growth rate over the forecast period, driven by their increasing demand.
• Clinical laboratory dominated the market with a revenue market share of 46.98% in 2023. In the rapidly advancing landscape of healthcare technology, Blood Gas Analyzers (BGAs) have become indispensable for clinical laboratories, offering real-time insights into a patient's respiratory and metabolic status.
• North America accounted for 42.22% of the blood gas and electrolyte analyzers market in 2023. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
• Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product and end-use outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Blood Gas and Electrolyte Analyzer Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of chronic diseases
    • 3.2.1.2. Rising geriatric population
    • 3.2.1.3. Increasing regulatory support and funding
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced analyzers
    • 3.2.2.2. Shortage of skilled professionals
• 3.3. Blood Gas and Electrolyte Analyzer Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Blood Gas and Electrolyte Analyzer Market: Product Estimates & Trend Analysis

• 4.1. Global Blood Gas and Electrolyte Analyzer Market: Product Dashboard
• 4.2. Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
• 4.3. Global Blood Gas and Electrolyte Analyzer Market by Product, Revenue
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.2. Instruments, by Type
  • 4.4.3. Bench Top
    • 4.4.3.1. Benchtop instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.4. Portable
    • 4.4.4.1. Portable instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.5. Instruments, by Brand
  • 4.4.6. I-STAT
    • 4.4.6.1. I-STAT market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.7. epoc
    • 4.4.7.1. epoc market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.8. GEM Premier (3500& 5000)
    • 4.4.8.1. GEM Premier (3500& 5000) market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.9. ABL Flex (90 and 800)
    • 4.4.9.1. ABL Flex (90 and 800) market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.10. Cobas
    • 4.4.10.1. Cobas market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.11. Portable RAPID Series
    • 4.4.11.1. RAPID series market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.12. Others
    • 4.4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Blood Gas and Electrolyte Analyzer Market: End Use Estimates & Trend Analysis

• 5.1. Global Blood Gas and Electrolyte Analyzer Market: End Use Dashboard
• 5.2. Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
• 5.3. Global Blood Gas and Electrolyte Analyzer Market by End Use, Revenue
• 5.4. Clinical Laboratory
  • 5.4.1. Clinical laboratory market estimates and forecasts 2018 - 2030 (USD Million)
• 5.5. Point-of-care
  • 5.5.1. Point-of-care market estimates and forecasts 2018 - 2030 (USD Million)
• 5.6. Diagnostic Centers
  • 5.6.1. Diagnostic centers market estimates and forecasts 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Blood Gas and Electrolyte Analyzer Market: Regional Estimates & Trend Analysis by Product and End Use

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.6. Singapore
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.7. Malaysia
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.8. Indonesia
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework/ reimbursement structure
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.9. Thailand
    • 6.5.9.1. Key country dynamics
    • 6.5.9.2. Regulatory framework/ reimbursement structure
    • 6.5.9.3. Competitive scenario
    • 6.5.9.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.10. Vietnam
    • 6.5.10.1. Key country dynamics
    • 6.5.10.2. Regulatory framework/ reimbursement structure
    • 6.5.10.3. Competitive scenario
    • 6.5.10.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.11. Philippines
    • 6.5.11.1. Key country dynamics
    • 6.5.11.2. Regulatory framework/ reimbursement structure
    • 6.5.11.3. Competitive scenario
    • 6.5.11.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6.2. Mexico
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Abbott
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Meizhou Cornley High-Tech Co., Ltd.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Radiometer Medical ApS
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. EDAN Instruments, Inc.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Erba Mannheim
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. F. Hoffmann-La Roche Ltd
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Fortress Diagnostics
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Werfen
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. LifeHealth
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Medica Corporation
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. OPTI Medical Systems, Inc.,
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives
  • 7.3.15. Sensa Core
    • 7.3.15.1. Company overview
    • 7.3.15.2. Financial performance
    • 7.3.15.3. Product benchmarking
    • 7.3.15.4. Strategic initiatives
  • 7.3.16. Siemens Healthineers AG
    • 7.3.16.1. Company overview
    • 7.3.16.2. Financial performance
    • 7.3.16.3. Product benchmarking
    • 7.3.16.4. Strategic initiatives